Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -5.96% is 65% above its 5-year average of -17.05%, near the high end of its 5-year range (-52.70%–7.00%).
254.01% below its 12-month average of 3.87%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -2.60%.
RETURN ON ASSETS (ROA)
-5.96%
RETURN ON ASSETS (ROA) AVG TTM
3.87%
RETURN ON ASSETS (ROA) AVG 3Y
-6.09%
RETURN ON ASSETS (ROA) AVG 5Y
-17.05%
RETURN ON ASSETS (ROA) AVG 10Y
-50.11%
RETURN ON ASSETS (ROA) AVG 15Y
-50.78%
RETURN ON ASSETS (ROA) AVG 20Y
-55.47%
CURRENT VS TTM AVG
-254.01%
CURRENT VS 3Y AVG
+2.17%
CURRENT VS 5Y AVG
+65.03%
CURRENT VS 10Y AVG
+88.11%
CURRENT VS 15Y AVG
+88.26%
CURRENT VS 20Y AVG
+89.26%
SECTOR MEDIAN · HEALTHCARE
-31.48%
median of 784 covered companies
CURRENT VS SECTOR MEDIAN
+81.06%
vs the sector median at left
MannKind Corporation
Market Cap
$1.22B
Return on Assets (ROA)
-5.96%
TTM Avg
3.87%
3Y Avg
-6.09%
5Y Avg
-17.05%
Market Cap
$1.22B
Return on Assets (ROA)
-0.46%
TTM Avg
-2.95%
3Y Avg
-4.25%
5Y Avg
-4.39%
Market Cap
$1.22B
Return on Assets (ROA)
5.91%
TTM Avg
1.36%
3Y Avg
-4.42%
5Y Avg
-8.30%
Market Cap
$1.23B
Return on Assets (ROA)
1.31%
TTM Avg
-17.71%
3Y Avg
-26.67%
5Y Avg
-26.67%
Market Cap
$1.24B
Return on Assets (ROA)
-34.68%
TTM Avg
-39.07%
3Y Avg
-38.32%
5Y Avg
-34.05%
Market Cap
$1.17B
Return on Assets (ROA)
-48.35%
TTM Avg
-102.84%
3Y Avg
-97.55%
5Y Avg
-75.48%
Market Cap
$1.27B
Return on Assets (ROA)
-49.10%
TTM Avg
-49.10%
3Y Avg
-49.10%
5Y Avg
-49.10%
Market Cap
$1.15B
Return on Assets (ROA)
-14.35%
TTM Avg
-48.83%
3Y Avg
-54.71%
5Y Avg
-49.10%
Market Cap
$1.15B
Return on Assets (ROA)
0.69%
TTM Avg
1.67%
3Y Avg
0.18%
5Y Avg
-3.47%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MannKind Corporation (MNKD) | $1.22B | -5.96% | 3.87% | -6.09% | -17.05% |
| Innovage Holding Corp. (INNV)vs › | $1.22B | -0.46% | -2.95% | -4.25% | -4.39% |
| Cronos Group Inc. (CRON)vs › | $1.22B | 5.91% | 1.36% | -4.42% | -8.30% |
| Omada Health (OMDA)vs › | $1.23B | 1.31% | -17.71% | -26.67% | -26.67% |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.24B | -34.68% | -39.07% | -38.32% | -34.05% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | -48.35% | -102.84% | -97.55% | -75.48% |
| Kardigan, Inc. (KARD)vs › | $1.27B | -49.10% | -49.10% | -49.10% | -49.10% |
| Nektar Therapeutics (NKTR)vs › | $1.15B | -14.35% | -48.83% | -54.71% | -49.10% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | 0.69% | 1.67% | 0.18% | -3.47% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | -57.23% | -57.23% | -57.23% | -57.23% |
ROA
-6.0%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 0.74% |
| 2024-12-31 | 7.00% |
| 2023-12-31 | -2.51% |
| 2022-12-31 | -29.60% |
| 2021-12-31 | -25.20% |
| 2020-12-31 | -52.70% |
| 2019-12-31 | -55.38% |
| 2018-12-31 | -80.75% |
| 2017-12-31 | -138.73% |
| 2016-12-31 | 117.37% |
| 2015-12-31 | -291.46% |
| 2014-12-31 | -50.29% |
| 2013-12-31 | -74.04% |
| 2012-12-31 | -67.39% |
| 2011-12-31 | -80.58% |
| 2010-12-31 | -61.52% |
| 2009-12-31 | -88.97% |
| 2008-12-31 | -107.29% |
| 2007-12-31 | -53.95% |
| 2006-12-31 | -42.71% |
| 2005-12-31 | -50.07% |
| 2004-12-31 | -46.48% |
| 2003-12-31 | -52.34% |
| 2002-12-31 | -196.87% |
| 2001-12-31 | 0.00% |
| 2000-12-31 | -57.83% |
